Suven Life Sciences Limited (BOM:530239)
India flag India · Delayed Price · Currency is INR
138.10
+1.85 (1.36%)
At close: Mar 6, 2026

Revenue by Segment

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17 Mar '16
Research and Development Services
66.56M116.93M135.95M119.51M140.73M
Research and Development Services Growth
-43.08%-13.99%13.76%-15.08%-4.30%
Total
66.56M116.93M135.95M119.51M140.73M
Total Growth
-43.08%-13.99%13.76%-15.08%-4.30%

Revenue by Geography

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17 Mar '16
India
47.31M28.97M83.92M62.98M51.25M
India Growth
63.32%-65.48%33.24%22.90%44.78%
United States of America (USA)
632.00K50.74M38.54M44.43M81.47M
United States of America (USA) Growth
-98.75%31.68%-13.26%-45.47%205.44%
Europe
3.49M24.39M2.04M1.39M2.06M
Europe Growth
-85.70%1095.64%46.76%-32.59%-97.18%
Rest of the World
15.13M12.83M10.90M9.64M-
Rest of the World Growth
17.94%17.75%13.00%--
Total
66.56M116.93M135.39M118.44M134.78M
Total Growth
-43.08%-13.64%14.31%-12.12%-6.50%
Source: S&P Global Market Intelligence.